Temat:
HUBTECH
Czy 20 milionowe obroty na spółce mogą być związane z prowadzonymi na świecie badaniami nad wykorzystaniem biosurfaktantów w zwalczaniu covid19? I nie chodzi tu o mycie i dezynfekcję rąk, tylko jako potencjalny lek zawierający biosurfaktanty. Czyżby Boruta też zamierzała wziąć w tym udział, może ktoś ma więcej informacji? Chyba, że te wzrosty to czysta spekulacja...Albo ich kosmetyki są takie dobre. Podaję link do opracowania naukowego na ten temat i kilka interesujących zdań wyjętych z niego. www.frontiersin.org/articles/1...translate.google.pl/translate?...“In this case, the use of biosurfactants in dealing with this pandemic justifies extensive study with their potential applications being in the prevention of viral spread; dealing with the symptoms that develop after the incubation period; directly targeting viral infected cells and preventing the spread of the virus throughout the host, all in addition to also acting as potential drug delivery systems and cleaning agents. This extensive avenue of biosurfactants owes to the simplicity in their amphiphilic structure which permits them to interact directly with the lipid membrane of the coronavirus, in a way which wouldn't be of significant threat to the host” "Biosurfactants Application in Acute Respiratory Distress Syndrome (ARDS) ARDS is often a consequence of an already serious medical concern, in this case Covid-19, with the resulting lack of oxygen to organs contributing to the high fatality rates seen in those who begin to develop symptoms. With this in mind, biosurfactants present themselves to be a promising area of study in identifying novel treatments for ARDS which could overcome the socioeconomic barriers that have so far limited the effectiveness of ventilators. It is for this reason that future study for their use as a direct treatment for ARDS, through solubilizing the alveolar substrate, is likely to generate positive results and is therefore crucial in combating Covid-19 in the future."
|